Latest news
Loading news…
Royalty Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 1996 11-50 employees For Profit
Industry leader in investing in marketed and late stage biopharmaceutical products
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
20
14 exits
Monthly Visits
Available in Pro Contacts
84
Ticker
RPRX
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- RPRX
- Exchange
- NASDAQ
- IPO date
- Jun 18, 2020
- Raised at IPO
- $2B
- Valuation at IPO
- $17B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- Active products
- 23
- IT spend
- $151M
Investor Activity
- Investor type
- Accelerator, Private Equity Firm
- Investments
- 20
- Lead investments
- 18
- Portfolio orgs
- 15
- Exits
- 14
- Exits via IPO
- 13
- Investment stages
- Early Stage Venture, Late Stage Venture
Company Info
- Founded
- 1996
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 2
- News articles
- 290
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Jun 18, 2020
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 3.6
- Trend (90d)
- -1.5
- Last leadership hire
- Mar 1, 2026
Investments by Royalty Pharma
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Royalty Pharma
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Royalty Pharma
Executive Vice President, Investments and General Counsel
Senior Vice President and Chief Technology Officer
Founder and CEO
Chief Scientific Officer, Executive Vice President, Head of Research and Investments
SVP Strategy and Analytics
Executive Vice President and Vice Chairman
Senior Vice President and Head of Asia
84
professional contacts at Royalty Pharma
Contact execs at Royalty Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Royalty Pharma
Loading news…
FAQs about Royalty Pharma
People who checked this page also checked these
Sectors Royalty Pharma invests & acquires in
Browse the full Acquirezy directory.